Abstract
Background: It was recently noted that a shortened activated partial thromboplastin time (aPTT) is associated with increased venous thromboembolic events. The prevalence of aPTT shortening remains unknown. Methods: We conducted a retrospective analysis of aPTT results over a 2-month period. These results were not associated with patient clinical information. Results: We obtained 3,376 aPTT samples, which were analyzed in groups: <25.0, 25.0-35.0, and >35.0 seconds (two standard deviations from our laboratory's normal values). Eighty-six samples had aPTT <25 (8.5%), 2,026 samples between 25.0-35.0 (60.0%), and 1,064 samples >35.0 (31.5%). Using chi-square goodness-of-fi t, we found a clinically signifi cant greater-than-expected prevalence of low aPTT levels (p < 0.001). Conclusions: Although elevated aPTT samples could be explained by anticoagulation therapy, the reason for our fi ndings of an increased number of low-aPTT studies remains unexplained. Further studies are required to investigate the clinical correlation of low aPTT levels and the incidence of venous thromboembolic events (VTEs) in our population. © Association of Military Surgeons of the U.S. All rights reserved.
Cite
CITATION STYLE
Smith, J. D., Amundson, D. E., & Harrell, T. (2011). Prevalence of short partial thromboplastin times in a military treatment facility. Military Medicine, 176(8), 956–958. https://doi.org/10.7205/MILMED-D-10-00165
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.